Topical lifitegrast therapy for dry eye disease

Authors

Lama Assi, LSU Health Sciences Center - New OrleansFollow
Salim C. Lutfallah, LSU Health Sciences Center - New OrleansFollow
Tsz Wing Yim, University of Colorado School of Medicine
Su Hsun Liu, University of Colorado School of Medicine
Sharon J. Duffy, LSU Health Sciences Center - New OrleansFollow
Jayne Weiss, LSU Health Sciences Center - New OrleansFollow

Document Type

Article

Publication Date

6-20-2025

Publication Title

Cochrane Database of Systematic Reviews

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effectiveness and safety of topical lifitegrast therapy alone or in combination with artificial tears, compared with a placebo, artificial tears alone, or no treatment for dry eye disease.

PubMed ID

40539519

Volume

2025

Issue

6

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Recommended Citation

Assi, Lama; Lutfallah, Salim C.; Yim, Tsz Wing; Liu, Su Hsun; Duffy, Sharon J.; and Weiss, Jayne, "Topical lifitegrast therapy for dry eye disease" (2025). School of Medicine Faculty Publications. 3866.
https://digitalscholar.lsuhsc.edu/som_facpubs/3866
10.1002/14651858.CD016117